试验速览
- 阶段
- 3 期
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Double blind comparative study
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
入选标准
- •Inclusion criteria:
- •Patient, age 20 years or older
- •Patients with urinary frequency and urge urinary incontinence
- •Exclusion criteria:
- •Patients who have diseases such as dysuria or urinary retention
- •Patients who have difficulty to void for myself
- •Patients with other diseases which may have been related to the state of urination. (ex urinary tract infection)
- •Patients with polyuria
- •Patients with diseases for which treatment with anticholinergic agents is contraindicated
- •Patients in whom precautions are required for the use of anticholinergic agents
- •Patients who have difficulty to use transdermal medications
排除标准
- 未提供
结局指标
主要结局
-
Efficacy and safety
次要结局
未报告次要终点
研究者
相似试验
未知
3 期
CS-801 phase 3 comparative studyOveractive bladderJPRN-jRCT2080220025Sankyo Co.,Ltd.
未知
3 期
CS-801 phase 3 long-term studyOveractive bladderJPRN-jRCT2080220026Sankyo Co.,Ltd.
未知
3 期
CS-866DM phase 3 comparative study (ORIENT)Type 2 diabetes and nephropathyJPRN-jRCT2080220027DAIICHISANKYO Co.,Ltd.
终止
3 期
WP-1303 Phase 3 comparison studyjRCT2080224836Wakamoto pharmaceutical Co., Ltd280
未知
3 期
CS-747S PhaseIII trialJPRN-jRCT2080221302DAIICHISANKYO Co.,Ltd.1,200